INSULIN ASPART

INSULIN ASPART was reported 63970 times

INSULIN ASPART is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 257 0.6641
1 SLEEP DISORDER THERAPY 119 0.6010
2 ANTACID THERAPY 78 0.6000
3 ULTRASOUND ANTENATAL SCREEN 51 0.5312
4 HEART SOUNDS 43 0.4479
5 ANALGESIC THERAPY 121 0.3769
6 DRUG THERAPY 114 0.3363
7 HYPERGLYCAEMIC UNCONSCIOUSNESS 41 0.3228
8 PULMONARY VASCULITIS 150 0.2788
9 TOTAL LUNG CAPACITY ABNORMAL 106 0.2725
10 ANTICOAGULANT THERAPY 76 0.2676
11 MALIGNANT MELANOMA STAGE 0 52 0.2488
12 CONGENITAL HIATUS HERNIA 55 0.2412
13 HYPOGLYCAEMIC UNCONSCIOUSNESS 402 0.2028
14 CAPILLARITIS 49 0.1775
15 PROLONGED EXPIRATION 44 0.1679
16 BACTEROIDES INFECTION 42 0.1609
17 HYPOGLYCAEMIC SEIZURE 139 0.1531
18 SPIROMETRY ABNORMAL 82 0.1371
19 MICROSPORIDIA INFECTION 38 0.1083
20 MITE ALLERGY 70 0.1069
21 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 76 0.1037
22 TRISOMY 18 37 0.0971
23 DIABETIC RETINOPATHY 324 0.0953
24 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 96 0.0904
25 NEPHROGENIC ANAEMIA 407 0.0878
26 INSULIN RESISTANCE 182 0.0874
27 NEURITIS 134 0.0867
28 SHOCK HYPOGLYCAEMIC 39 0.0819
29 MYCOTIC ALLERGY 70 0.0819
30 HYPERPHOSPHATAEMIA 164 0.0762
31 HYPERPARATHYROIDISM SECONDARY 191 0.0762
32 BLOOD GLUCOSE FLUCTUATION 835 0.0761
33 DUST ALLERGY 72 0.0734
34 BLOOD GLUCOSE DECREASED 3443 0.0716
35 BLOOD PHOSPHORUS INCREASED 195 0.0714
36 HYPOGLYCAEMIC COMA 202 0.0700
37 HYDROPS FOETALIS 41 0.0669
38 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 60 0.0647
39 RESPIRATORY SYMPTOM 182 0.0639
40 DIABETES MELLITUS INADEQUATE CONTROL 1062 0.0599
41 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 120 0.0588
42 DIABETIC KETOACIDOSIS 1392 0.0579
43 BLOOD GLUCOSE INCREASED 10783 0.0572
44 NEUROPATHIC ARTHROPATHY 36 0.0556
45 CONJUNCTIVITIS ALLERGIC 81 0.0547
46 DIABETIC NEUROPATHY 267 0.0539
47 GLYCOSYLATED HAEMOGLOBIN INCREASED 1255 0.0497
48 CORRECTIVE LENS USER 46 0.0472
49 END STAGE RENAL DISEASE 823 0.0451
50 DIABETIC METABOLIC DECOMPENSATION 60 0.0432
51 DIABETIC FOOT 129 0.0421
52 GASTROINTESTINAL HYPOMOTILITY 93 0.0412
53 DIABETIC COMA 115 0.0410
54 OESOPHAGEAL SPASM 73 0.0396
55 FORCED EXPIRATORY VOLUME DECREASED 111 0.0391
56 REBOUND ACID HYPERSECRETION 116 0.0383
57 IMPAIRED GASTRIC EMPTYING 513 0.0376
58 OBSTRUCTIVE SLEEP APNOEA SYNDROME 53 0.0363
59 DIABETIC NEPHROPATHY 80 0.0363
60 TOTAL LUNG CAPACITY DECREASED 58 0.0363
61 BLOOD GLUCOSE ABNORMAL 663 0.0359
62 ADENOCARCINOMA PANCREAS 46 0.0358
63 HYPOGLYCAEMIA 1714 0.0353
64 CLEFT LIP AND PALATE 39 0.0349
65 RENAL TRANSPLANT 123 0.0340
66 FOOT AMPUTATION 48 0.0330
67 AORTIC STENOSIS 109 0.0313
68 GLYCOSYLATED HAEMOGLOBIN DECREASED 50 0.0310
69 NORMOCHROMIC NORMOCYTIC ANAEMIA 92 0.0306
70 URINE KETONE BODY PRESENT 48 0.0304
71 DIABETIC COMPLICATION 77 0.0302
72 WRONG DRUG ADMINISTERED 265 0.0297
73 APPENDICITIS 277 0.0296
74 ESSENTIAL HYPERTENSION 54 0.0295
75 BLOOD URIC ACID INCREASED 169 0.0292
76 IRON DEFICIENCY 128 0.0284
77 LEG AMPUTATION 117 0.0284
78 LIQUID PRODUCT PHYSICAL ISSUE 199 0.0273
79 PULMONARY ALVEOLAR HAEMORRHAGE 148 0.0264
80 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 143 0.0262
81 TOE AMPUTATION 132 0.0260
82 HYPERGLYCAEMIA 927 0.0254
83 MYASTHENIA GRAVIS 205 0.0254
84 PANCREATIC CARCINOMA METASTATIC 72 0.0253
85 HYPOPHOSPHATAEMIA 186 0.0251
86 VENTRICULAR FIBRILLATION 279 0.0251
87 HYPOGLYCAEMIA NEONATAL 39 0.0241
88 NEUROLOGICAL SYMPTOM 133 0.0232
89 KETOACIDOSIS 171 0.0228
90 RETINOPATHY 85 0.0228
91 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 115 0.0227
92 DEVICE FAILURE 331 0.0217
93 CHRONIC KIDNEY DISEASE 1641 0.0216
94 CYSTIC FIBROSIS 116 0.0209
95 CATARACT OPERATION 124 0.0209
96 ARTERIOSCLEROSIS CORONARY ARTERY 138 0.0208
97 EARLY SATIETY 40 0.0205
98 LUNG OPACITY 54 0.0205
99 TYPE 1 DIABETES MELLITUS 123 0.0204
100 CARDIOGENIC SHOCK 284 0.0198
101 HYPERLIPIDAEMIA 235 0.0196
102 RALES 113 0.0194
103 PLEURITIC PAIN 53 0.0192
104 PANCREATIC DISORDER 91 0.0185
105 TROPONIN INCREASED 139 0.0183
106 WRONG PRODUCT ADMINISTERED 122 0.0180
107 OESOPHAGEAL PAIN 70 0.0177
108 GANGRENE 102 0.0169
109 FULL BLOOD COUNT ABNORMAL 179 0.0169
110 VASCULAR GRAFT 47 0.0163
111 ARTERIOSCLEROSIS 150 0.0159
112 LYMPHOEDEMA 108 0.0156
113 RENAL FAILURE CHRONIC 120 0.0156
114 EYE HAEMORRHAGE 208 0.0156
115 DEVICE OPERATIONAL ISSUE 67 0.0156
116 BENIGN PROSTATIC HYPERPLASIA 80 0.0155
117 PANCREATITIS CHRONIC 36 0.0152
118 NECROTISING FASCIITIS 53 0.0150
119 OBSTRUCTIVE AIRWAYS DISORDER 166 0.0149
120 BLINDNESS UNILATERAL 204 0.0144
121 POOR PERIPHERAL CIRCULATION 61 0.0143
122 MACULAR DEGENERATION 171 0.0143
123 CARDIAC OPERATION 122 0.0142
124 GOUT 252 0.0140
125 METABOLIC ENCEPHALOPATHY 42 0.0140
126 BLOOD CALCIUM INCREASED 122 0.0139
127 NEPHROPATHY 127 0.0136
128 BREATH SOUNDS ABNORMAL 67 0.0136
129 RENAL INJURY 403 0.0136
130 CORONARY ARTERY OCCLUSION 186 0.0135
131 WHEELCHAIR USER 60 0.0135
132 EYE OPERATION 62 0.0134
133 WOUND COMPLICATION 46 0.0134
134 ACCIDENTAL UNDERDOSE 192 0.0133
135 DEPRESSIVE SYMPTOM 47 0.0133
136 SLEEP APNOEA SYNDROME 254 0.0133
137 VASCULITIS 154 0.0132
138 ABSCESS LIMB 55 0.0129
139 ASCITES 377 0.0128
140 HAEMORRHAGIC ANAEMIA 56 0.0127
141 BACTERIAL INFECTION 232 0.0124
142 BLINDNESS 505 0.0124
143 CAROTID ARTERY OCCLUSION 45 0.0123
144 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 209 0.0123
145 CORONARY ARTERY BYPASS 70 0.0122
146 RENAL FAILURE 1615 0.0122
147 MULTIPLE ORGAN DYSFUNCTION SYNDROME 342 0.0121
148 APPETITE DISORDER 80 0.0121
149 TRIGGER FINGER 49 0.0120
150 DIALYSIS 169 0.0119
151 STENT PLACEMENT 96 0.0119
152 EUGLYCAEMIC DIABETIC KETOACIDOSIS 49 0.0119
153 RETINAL HAEMORRHAGE 84 0.0118
154 VISUAL IMPAIRMENT 1437 0.0116
155 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 198 0.0115
156 ACUTE KIDNEY INJURY 1753 0.0114
157 HYPOVOLAEMIA 67 0.0114
158 FLANK PAIN 107 0.0114
159 DISABILITY 223 0.0113
160 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 46 0.0113
161 PERIPHERAL VASCULAR DISORDER 58 0.0112
162 THERAPEUTIC PRODUCT EFFECT DELAYED 51 0.0112
163 PRODUCT STORAGE ISSUE 42 0.0111
164 PULMONARY FIBROSIS 212 0.0110
165 BLOOD POTASSIUM INCREASED 179 0.0110
166 CATARACT 656 0.0110
167 ORTHOPNOEA 35 0.0110
168 DIABETES MELLITUS 826 0.0108
169 DRUG DISPENSING ERROR 165 0.0108
170 OSTEOMYELITIS 194 0.0107
171 CARPAL TUNNEL SYNDROME 149 0.0106
172 CAROTID ARTERY STENOSIS 37 0.0106
173 LOCALISED INFECTION 256 0.0106
174 PRODUCT QUALITY ISSUE 1437 0.0106
175 NEURALGIA 255 0.0105
176 ULCER 164 0.0103
177 DECUBITUS ULCER 84 0.0103
178 HUNGER 140 0.0100
179 RETINAL DETACHMENT 92 0.0100
180 DEVICE MECHANICAL ISSUE 137 0.0100
181 SKIN ULCER 257 0.0099
182 HYPERVOLAEMIA 49 0.0099
183 RENAL TUBULAR NECROSIS 97 0.0099
184 ESCHERICHIA URINARY TRACT INFECTION 42 0.0099
185 CORONARY ARTERIAL STENT INSERTION 50 0.0099
186 MALNUTRITION 110 0.0098
187 BLOOD MAGNESIUM DECREASED 84 0.0097
188 INCORRECT PRODUCT STORAGE 127 0.0097
189 HAEMOPTYSIS 269 0.0096
190 RESPIRATION ABNORMAL 66 0.0096
191 UROSEPSIS 88 0.0095
192 FLUID OVERLOAD 138 0.0095
193 CARDIAC FAILURE CONGESTIVE 760 0.0095
194 ARTERIAL OCCLUSIVE DISEASE 74 0.0094
195 INJECTION SITE INJURY 52 0.0094
196 DIVERTICULUM INTESTINAL 41 0.0094
197 LEFT VENTRICULAR HYPERTROPHY 40 0.0093
198 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 487 0.0093
199 ASPIRATION 100 0.0091
200 ACUTE RESPIRATORY FAILURE 175 0.0091
201 CORONARY ARTERY DISEASE 275 0.0091
202 FLUID RETENTION 456 0.0090
203 NODULE 117 0.0090
204 HYPERKALAEMIA 313 0.0089
205 GLAUCOMA 171 0.0089
206 TUBULOINTERSTITIAL NEPHRITIS 166 0.0088
207 INTENTIONAL DEVICE MISUSE 39 0.0088
208 BLINDNESS TRANSIENT 65 0.0088
209 GOITRE 36 0.0088
210 SUBCUTANEOUS ABSCESS 42 0.0088
211 ERUCTATION 169 0.0087
212 EXPIRED DRUG ADMINISTERED 43 0.0087
213 CELLULITIS 436 0.0086
214 HYPERNATRAEMIA 43 0.0086
215 ATELECTASIS 83 0.0086
216 MULTIPLE USE OF SINGLE-USE PRODUCT 48 0.0085
217 HYPONATRAEMIA 476 0.0084
218 AMMONIA INCREASED 43 0.0084
219 RENAL DISORDER 391 0.0084
220 HYPOACUSIS 361 0.0084
221 DEHYDRATION 1117 0.0084
222 KIDNEY TRANSPLANT REJECTION 40 0.0083
223 NEUROPATHY PERIPHERAL 792 0.0083
224 PANCREATITIS 440 0.0083
225 TRANSIENT ISCHAEMIC ATTACK 279 0.0083
226 IRON DEFICIENCY ANAEMIA 76 0.0082
227 SEPSIS 913 0.0082
228 HYPERCHOLESTEROLAEMIA 79 0.0082
229 HEPATIC STEATOSIS 152 0.0082
230 HYPERKERATOSIS 45 0.0081
231 BLOOD CREATINE INCREASED 36 0.0081
232 DEVICE MALFUNCTION 570 0.0081
233 HEPATIC CIRRHOSIS 152 0.0081
234 INJECTION SITE NODULE 89 0.0081
235 MACULAR OEDEMA 45 0.0080
236 ATRIAL FLUTTER 64 0.0080
237 OVERWEIGHT 43 0.0080
238 MENTAL STATUS CHANGES 222 0.0080
239 LIMB INJURY 217 0.0080
240 HYPOXIA 281 0.0080
241 ABDOMINAL DISTENSION 829 0.0079
242 NERVE INJURY 88 0.0079
243 PULSE ABSENT 37 0.0078
244 ANKLE FRACTURE 120 0.0077
245 GLOMERULAR FILTRATION RATE DECREASED 95 0.0077
246 INCOHERENT 50 0.0077
247 JOINT INJURY 165 0.0077
248 FAILURE TO THRIVE 40 0.0077
249 HYPOTHYROIDISM 246 0.0077
250 BLOOD POTASSIUM DECREASED 229 0.0076
251 BLOOD TEST ABNORMAL 107 0.0076
252 WALKING AID USER 50 0.0076
253 BACK DISORDER 123 0.0076
254 DEMENTIA 211 0.0075
255 DRUG ADMINISTRATION ERROR 231 0.0075
256 STAPHYLOCOCCAL INFECTION 248 0.0075
257 BLOOD CHOLESTEROL INCREASED 350 0.0075
258 BLOOD UREA INCREASED 125 0.0075
259 CYSTITIS 235 0.0074
260 THROMBOSIS 592 0.0074
261 PRODUCT DISPENSING ERROR 160 0.0073
262 RENAL FAILURE ACUTE 311 0.0073
263 MICTURITION URGENCY 83 0.0073
264 INCREASED APPETITE 138 0.0072
265 CARDIAC PACEMAKER INSERTION 43 0.0072
266 KIDNEY INFECTION 141 0.0072
267 VARICOSE VEIN 37 0.0072
268 CEREBROVASCULAR ACCIDENT 1201 0.0071
269 DYSLIPIDAEMIA 36 0.0071
270 LOWER LIMB FRACTURE 136 0.0071
271 PANCREATITIS ACUTE 159 0.0071
272 CARDIOMEGALY 87 0.0071
273 HEPATIC ENCEPHALOPATHY 66 0.0071
274 EYE DISORDER 232 0.0070
275 RENAL CYST 56 0.0070
276 PYELONEPHRITIS 61 0.0070
277 CARDIAC VALVE DISEASE 40 0.0070
278 THIRST 125 0.0070
279 VISUAL ACUITY REDUCED 232 0.0070
280 EXPIRED PRODUCT ADMINISTERED 232 0.0070
281 BRONCHIECTASIS 47 0.0070
282 CONCUSSION 54 0.0070
283 INJECTION SITE EXTRAVASATION 86 0.0070
284 FOOT FRACTURE 132 0.0070
285 ESCHERICHIA INFECTION 57 0.0069
286 PRODUCTIVE COUGH 328 0.0069
287 FIBROMYALGIA 166 0.0068
288 OBESITY 108 0.0068
289 WEIGHT DECREASED 1890 0.0068
290 LOWER GASTROINTESTINAL HAEMORRHAGE 50 0.0068
291 ECONOMIC PROBLEM 102 0.0067
292 LUNG DISORDER 329 0.0067
293 PRODUCT COMMUNICATION ISSUE 59 0.0067
294 ILEUS 83 0.0067
295 INCORRECT DOSE ADMINISTERED BY DEVICE 175 0.0067
296 MULTIPLE INJURIES 42 0.0067
297 UNRESPONSIVE TO STIMULI 172 0.0067
298 LEUKOCYTOSIS 120 0.0066
299 SPINAL OSTEOARTHRITIS 58 0.0066
300 INTERVERTEBRAL DISC DEGENERATION 61 0.0066
301 LACERATION 62 0.0066
302 HOSPICE CARE 65 0.0066
303 GENERALISED OEDEMA 81 0.0065
304 ROTATOR CUFF SYNDROME 84 0.0065
305 HYPOPHAGIA 167 0.0065
306 HYPERHIDROSIS 841 0.0065
307 CHOLELITHIASIS 214 0.0065
308 BLOOD CREATININE INCREASED 424 0.0065
309 VITAMIN D DEFICIENCY 63 0.0065
310 PANCREATIC CARCINOMA 185 0.0064
311 PRODUCT ODOUR ABNORMAL 67 0.0064
312 ROAD TRAFFIC ACCIDENT 267 0.0064
313 CARDIAC MURMUR 55 0.0064
314 WOUND 177 0.0063
315 UPPER LIMB FRACTURE 126 0.0063
316 WHEEZING 375 0.0063
317 DYSPNOEA EXERTIONAL 238 0.0063
318 INTERVERTEBRAL DISC PROTRUSION 138 0.0063
319 FUNGAL INFECTION 210 0.0063
320 DIZZINESS POSTURAL 61 0.0063
321 CONSTIPATION 1365 0.0063
322 GASTROENTERITIS VIRAL 113 0.0063
323 ANGINA PECTORIS 179 0.0062
324 HYPOTHERMIA 63 0.0062
325 HAND FRACTURE 44 0.0062
326 GASTROOESOPHAGEAL REFLUX DISEASE 499 0.0062
327 INJECTION SITE HAEMORRHAGE 492 0.0062
328 UPPER RESPIRATORY TRACT INFECTION 284 0.0061
329 INJECTION SITE MASS 227 0.0061
330 EXOSTOSIS 56 0.0061
331 WEIGHT INCREASED 1373 0.0061
332 POLYP 40 0.0061
333 DECREASED INTEREST 36 0.0061
334 COVID-19 PNEUMONIA 72 0.0061
335 FOETAL GROWTH RESTRICTION 37 0.0061
336 ATRIOVENTRICULAR BLOCK 47 0.0061
337 OEDEMA PERIPHERAL 741 0.0061
338 ACUTE MYOCARDIAL INFARCTION 179 0.0061
339 NERVE COMPRESSION 56 0.0061
340 DECREASED APPETITE 1409 0.0061
341 BLOOD SODIUM DECREASED 114 0.0060
342 MENISCUS INJURY 37 0.0060
343 COLD SWEAT 106 0.0060
344 MITRAL VALVE INCOMPETENCE 68 0.0060
345 ATRIAL FIBRILLATION 585 0.0060
346 BACTERAEMIA 71 0.0060
347 PRODUCT STORAGE ERROR 519 0.0059
348 PRE-EXISTING CONDITION IMPROVED 37 0.0059
349 LOSS OF CONSCIOUSNESS 756 0.0059
350 POLLAKIURIA 245 0.0059
351 ABNORMAL LOSS OF WEIGHT 40 0.0059
352 CHOLECYSTECTOMY 67 0.0059
353 BRONCHITIS 434 0.0059
354 SLEEP DISORDER 413 0.0058
355 MYOCARDIAL INFARCTION 1020 0.0058
356 WOUND INFECTION 64 0.0058
357 LACTIC ACIDOSIS 188 0.0058
358 URINARY TRACT INFECTION 989 0.0058
359 HIATUS HERNIA 75 0.0058
360 INFUSION SITE PAIN 74 0.0057
361 WEIGHT FLUCTUATION 60 0.0057
362 FALL 1905 0.0057
363 PSEUDOMONAS INFECTION 49 0.0057
364 THYROID DISORDER 88 0.0057
365 ARTHRITIS 449 0.0057
366 VITREOUS FLOATERS 56 0.0057
367 INTERNAL HAEMORRHAGE 65 0.0057
368 LEFT VENTRICULAR DYSFUNCTION 38 0.0057
369 ANAL INCONTINENCE 51 0.0057
370 ARTHROPOD BITE 42 0.0057
371 ANOREXIA 73 0.0057
372 TRICUSPID VALVE INCOMPETENCE 45 0.0057
373 BLOOD TRIGLYCERIDES INCREASED 100 0.0057
374 HEPATIC CYTOLYSIS 72 0.0056
375 POSTOPERATIVE WOUND INFECTION 38 0.0056
376 VISION BLURRED 771 0.0056
377 SCAR 96 0.0056
378 SPINAL OPERATION 69 0.0056
379 HEAD INJURY 177 0.0056
380 RIB FRACTURE 115 0.0056
381 SPUTUM DISCOLOURED 53 0.0056
382 HOSPITALISATION 858 0.0056
383 UPPER-AIRWAY COUGH SYNDROME 46 0.0056
384 PULMONARY MASS 83 0.0056
385 INTENTIONAL PRODUCT MISUSE 487 0.0056
386 PSYCHOLOGICAL TRAUMA 48 0.0056
387 LUNG INFILTRATION 49 0.0055
388 ANGINA UNSTABLE 36 0.0055
389 DRY MOUTH 449 0.0055
390 TYPE 2 DIABETES MELLITUS 186 0.0055
391 PERIPHERAL SWELLING 847 0.0055
392 CAESAREAN SECTION 64 0.0055
393 CARDIAC DISORDER 514 0.0055
394 BRAIN INJURY 55 0.0055
395 SWELLING 513 0.0055
396 VOMITING 2575 0.0055
397 HAIR DISORDER 45 0.0055
398 PRURITUS GENERALISED 118 0.0055
399 GASTROINTESTINAL HAEMORRHAGE 455 0.0054
400 ACCIDENT 65 0.0054
401 PLEURAL EFFUSION 330 0.0054
402 UPPER GASTROINTESTINAL HAEMORRHAGE 91 0.0054
403 PULMONARY OEDEMA 241 0.0054
404 SPLENOMEGALY 63 0.0054
405 ABDOMINAL PAIN 1250 0.0054
406 DIVERTICULUM 38 0.0053
407 HYPERSOMNIA 153 0.0053
408 INABILITY TO AFFORD MEDICATION 53 0.0053
409 HAIR COLOUR CHANGES 66 0.0053
410 METABOLIC ACIDOSIS 169 0.0053
411 SMALL INTESTINAL OBSTRUCTION 65 0.0053
412 HAEMORRHAGIC STROKE 41 0.0052
413 HYPOMAGNESAEMIA 73 0.0052
414 ANAEMIA 999 0.0052
415 TREMOR 869 0.0052
416 ACIDOSIS 40 0.0052
417 BLOOD PRESSURE ABNORMAL 104 0.0052
418 FEEDING DISORDER 106 0.0052
419 PRODUCT USE COMPLAINT 82 0.0052
420 MUSCLE DISORDER 42 0.0052
421 KNEE OPERATION 51 0.0052
422 PULMONARY EMBOLISM 491 0.0052
423 MEMORY IMPAIRMENT 708 0.0051
424 BACK INJURY 56 0.0051
425 RENAL IMPAIRMENT 432 0.0051
426 ANHEDONIA 135 0.0051
427 CHOLECYSTITIS 61 0.0051
428 PRODUCT DOSE OMISSION 334 0.0051
429 CHEST PAIN 947 0.0051
430 TREATMENT NONCOMPLIANCE 279 0.0051
431 BOWEL MOVEMENT IRREGULARITY 39 0.0051
432 OEDEMA 276 0.0051
433 FRUSTRATION TOLERANCE DECREASED 41 0.0051
434 GENERAL PHYSICAL HEALTH DETERIORATION 583 0.0050
435 VITAMIN D DECREASED 43 0.0050
436 NAUSEA 3979 0.0050
437 ASPARTATE AMINOTRANSFERASE INCREASED 267 0.0050
438 SEASONAL ALLERGY 71 0.0050
439 PHARYNGEAL SWELLING 49 0.0050
440 LETHARGY 288 0.0050
441 PNEUMONIA 1620 0.0050
442 CLOSTRIDIUM DIFFICILE COLITIS 53 0.0050
443 DRUG PRESCRIBING ERROR 96 0.0050
444 HICCUPS 41 0.0050
445 HYPERTENSION 1058 0.0050
446 GALLBLADDER DISORDER 89 0.0050
447 FLATULENCE 281 0.0050
448 OSTEOARTHRITIS 210 0.0049
449 GASTRITIS 129 0.0049
450 ASTHMA 554 0.0049
451 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 235 0.0049
452 BLOOD IRON DECREASED 58 0.0049
453 HEPATOMEGALY 48 0.0049
454 INJECTION SITE DISCOLOURATION 61 0.0049
455 INJECTION SITE BRUISING 389 0.0049
456 INJURY ASSOCIATED WITH DEVICE 99 0.0049
457 DYSPEPSIA 477 0.0048
458 LIMB DISCOMFORT 150 0.0048
459 RETCHING 103 0.0048
460 SCIATICA 77 0.0048
461 ABSCESS 77 0.0048
462 INCONTINENCE 51 0.0048
463 ORTHOSTATIC HYPOTENSION 84 0.0048
464 HEART RATE IRREGULAR 109 0.0048
465 ABDOMINAL PAIN UPPER 993 0.0048
466 PRESYNCOPE 117 0.0048
467 FURUNCLE 38 0.0048
468 INJECTION SITE IRRITATION 61 0.0048
469 INJECTION SITE INDURATION 62 0.0048
470 SKIN LACERATION 52 0.0048
471 FEELING JITTERY 91 0.0048
472 INTERNATIONAL NORMALISED RATIO INCREASED 136 0.0048
473 CARDIOVASCULAR DISORDER 121 0.0048
474 PULMONARY HYPERTENSION 99 0.0047
475 DYSPNOEA 2680 0.0047
476 ELECTROCARDIOGRAM ABNORMAL 37 0.0047
477 SLUGGISHNESS 48 0.0047
478 URINE OUTPUT DECREASED 41 0.0047
479 SHOCK HAEMORRHAGIC 38 0.0047
480 ASTHENIA 1754 0.0047
481 BLOOD ALBUMIN DECREASED 37 0.0047
482 POST PROCEDURAL COMPLICATION 89 0.0046
483 DRUG DOSE OMISSION 764 0.0046
484 RESTLESS LEGS SYNDROME 84 0.0046
485 NEPHROLITHIASIS 211 0.0046
486 SUPRAVENTRICULAR TACHYCARDIA 44 0.0046
487 HAEMATOCRIT DECREASED 91 0.0046
488 MEDICATION ERROR 255 0.0046
489 PULMONARY THROMBOSIS 50 0.0046
490 HAEMOLYTIC ANAEMIA 41 0.0046
491 LIPASE INCREASED 35 0.0046
492 DISORIENTATION 181 0.0046
493 ELECTROLYTE IMBALANCE 53 0.0046
494 PAIN IN EXTREMITY 1343 0.0046
495 CONFUSIONAL STATE 736 0.0045
496 URINARY INCONTINENCE 134 0.0045
497 GASTROENTERITIS 66 0.0045
498 GAIT INABILITY 151 0.0045
499 LIVER FUNCTION TEST INCREASED 97 0.0045
500 MYOPATHY 39 0.0045
501 MUSCLE STRAIN 39 0.0045
502 HYPOKALAEMIA 208 0.0045
503 COLON CANCER 67 0.0045
504 DYSARTHRIA 168 0.0045
505 PERICARDIAL EFFUSION 103 0.0045
506 AMNESIA 289 0.0044
507 COAGULOPATHY 74 0.0044
508 DEVICE ISSUE 398 0.0044
509 CYST 55 0.0044
510 BLADDER DISORDER 44 0.0044
511 SOMNOLENCE 892 0.0044
512 WRIST FRACTURE 53 0.0044
513 INJECTION SITE HAEMATOMA 64 0.0044
514 HAEMORRHOIDS 86 0.0044
515 DEAFNESS 115 0.0044
516 POLYURIA 36 0.0044
517 MYOCARDIAL ISCHAEMIA 50 0.0044
518 TASTE DISORDER 89 0.0044
519 COELIAC DISEASE 43 0.0044
520 HAEMATURIA 150 0.0044
521 RECTAL HAEMORRHAGE 188 0.0044
522 MASS 61 0.0044
523 NERVOUSNESS 228 0.0044
524 PERITONITIS BACTERIAL 44 0.0044
525 MUSCULOSKELETAL DISCOMFORT 75 0.0044
526 ENCEPHALOPATHY 107 0.0044
527 RESPIRATORY DISTRESS 120 0.0043
528 PREMATURE DELIVERY 69 0.0043
529 INCORRECT DOSE ADMINISTERED 985 0.0043
530 PHARMACEUTICAL PRODUCT COMPLAINT 112 0.0043
531 POST PROCEDURAL INFECTION 35 0.0043
532 SINUS CONGESTION 58 0.0043
533 HIP FRACTURE 138 0.0043
534 ILLNESS 442 0.0043
535 DYSSTASIA 125 0.0043
536 HYPOKINESIA 62 0.0043
537 DEPRESSION 968 0.0043
538 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37 0.0042
539 MENTAL IMPAIRMENT 103 0.0042
540 DIZZINESS 2119 0.0042
541 SINUS BRADYCARDIA 41 0.0042
542 FEELING ABNORMAL 1015 0.0042
543 MALAISE 1847 0.0042
544 OESOPHAGITIS 46 0.0042
545 INTENTIONAL DOSE OMISSION 120 0.0042
546 DIARRHOEA 2707 0.0042
547 INFLUENZA 467 0.0042
548 CONDITION AGGRAVATED 1273 0.0042
549 DYSURIA 154 0.0042
550 HYPOTENSION 837 0.0042
551 PULMONARY CONGESTION 55 0.0042
552 BONE DISORDER 76 0.0042
553 EYE INFECTION 47 0.0042
554 DEVICE RELATED INFECTION 64 0.0042
555 LIVER DISORDER 184 0.0041
556 LIGAMENT SPRAIN 41 0.0041
557 SINUS DISORDER 82 0.0041
558 HEMIPARESIS 70 0.0041
559 TENDERNESS 43 0.0041
560 NOCTURIA 50 0.0041
561 SURGERY 241 0.0041
562 UNDERDOSE 300 0.0041
563 BALANCE DISORDER 355 0.0041
564 TRANSFUSION 43 0.0041
565 SPINAL FRACTURE 82 0.0041
566 BLOOD CALCIUM DECREASED 46 0.0041
567 EATING DISORDER 87 0.0041
568 OSTEOPENIA 62 0.0041
569 IMPAIRED HEALING 133 0.0040
570 SKIN LESION 111 0.0040
571 GAIT DISTURBANCE 774 0.0040
572 MUSCLE SPASMS 742 0.0040
573 OXYGEN SATURATION DECREASED 227 0.0040
574 SYNCOPE 404 0.0040
575 LEUKAEMIA 38 0.0040
576 CHEST DISCOMFORT 412 0.0040
577 ANXIETY 1142 0.0040
578 DEVICE LEAKAGE 174 0.0040
579 MUSCULAR WEAKNESS 456 0.0040
580 INTESTINAL OBSTRUCTION 151 0.0040
581 PALLOR 109 0.0040
582 LACRIMATION INCREASED 121 0.0040
583 AUTOIMMUNE DISORDER 39 0.0040
584 INJECTION SITE DISCOMFORT 42 0.0040
585 CARDIOMYOPATHY 59 0.0040
586 BLOOD PRESSURE INCREASED 609 0.0040
587 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 804 0.0040
588 NASAL CONGESTION 233 0.0040
589 HAIR TEXTURE ABNORMAL 53 0.0040
590 JOINT RANGE OF MOTION DECREASED 53 0.0039
591 RESPIRATORY FAILURE 288 0.0039
592 SWOLLEN TONGUE 123 0.0039
593 BLOOD PRESSURE DECREASED 261 0.0039
594 ABASIA 97 0.0039
595 DEVICE DEFECTIVE 68 0.0039
596 MUSCULOSKELETAL PAIN 205 0.0039
597 BACK PAIN 909 0.0039
598 CARDIAC FAILURE 314 0.0039
599 BLOOD URINE PRESENT 74 0.0039
600 DECREASED ACTIVITY 42 0.0039
601 BRADYCARDIA 206 0.0039
602 TOOTH INFECTION 51 0.0039
603 HAEMATEMESIS 98 0.0039
604 POST PROCEDURAL HAEMORRHAGE 45 0.0039
605 THINKING ABNORMAL 72 0.0039
606 BLISTER 217 0.0039
607 LOWER RESPIRATORY TRACT INFECTION 175 0.0038
608 HYPOAESTHESIA ORAL 58 0.0038
609 UNEVALUABLE EVENT 291 0.0038
610 FEELING COLD 107 0.0038
611 LOCAL SWELLING 67 0.0038
612 INJECTION SITE PAIN 1178 0.0038
613 HERNIA 74 0.0038
614 BLOOD ALKALINE PHOSPHATASE INCREASED 95 0.0038
615 PNEUMONIA BACTERIAL 35 0.0038
616 SINUS TACHYCARDIA 54 0.0038
617 SPINAL DISORDER 36 0.0038
618 KNEE ARTHROPLASTY 80 0.0038
619 PALPITATIONS 444 0.0038
620 SCAB 43 0.0038
621 EMPHYSEMA 38 0.0038
622 NEOPLASM MALIGNANT 251 0.0038
623 HAEMOGLOBIN DECREASED 386 0.0038
624 BLADDER CANCER 221 0.0037
625 SEPTIC SHOCK 163 0.0037
626 BODY HEIGHT DECREASED 40 0.0037
627 CONTUSION 360 0.0037
628 ILL-DEFINED DISORDER 227 0.0037
629 RASH PRURITIC 202 0.0037
630 ABDOMINAL DISCOMFORT 625 0.0037
631 CLOSTRIDIUM DIFFICILE INFECTION 81 0.0037
632 COUGH 1039 0.0037
633 MADAROSIS 43 0.0037
634 DIPLOPIA 96 0.0037
635 MUSCULOSKELETAL CHEST PAIN 57 0.0037
636 TACHYPNOEA 50 0.0037
637 VIRAL INFECTION 122 0.0037
638 SKIN INFECTION 41 0.0037
639 PERIPHERAL COLDNESS 50 0.0036
640 GASTROINTESTINAL PAIN 40 0.0036
641 DRUG INTOLERANCE 351 0.0036
642 EYE PAIN 205 0.0036
643 INFECTION 525 0.0036
644 FULL BLOOD COUNT DECREASED 73 0.0036
645 IMPAIRED QUALITY OF LIFE 52 0.0036
646 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 651 0.0036
647 STOMATITIS 219 0.0036
648 ACCIDENTAL OVERDOSE 132 0.0036
649 IMPAIRED DRIVING ABILITY 41 0.0036
650 INSURANCE ISSUE 55 0.0036
651 FATIGUE 2794 0.0036
652 RESPIRATORY TRACT CONGESTION 57 0.0036
653 TINNITUS 164 0.0036
654 RED BLOOD CELL COUNT DECREASED 102 0.0036
655 EYE DISCHARGE 37 0.0036
656 RASH GENERALISED 92 0.0035
657 RHINORRHOEA 229 0.0035
658 ALANINE AMINOTRANSFERASE INCREASED 217 0.0035
659 HEART RATE INCREASED 350 0.0035
660 EXTRA DOSE ADMINISTERED 143 0.0035
661 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 251 0.0035
662 SCRATCH 37 0.0035
663 COVID-19 615 0.0035
664 EPISTAXIS 261 0.0035
665 FEMUR FRACTURE 108 0.0035
666 PNEUMONIA ASPIRATION 87 0.0035
667 RHABDOMYOLYSIS 145 0.0035
668 PROTEINURIA 66 0.0035
669 INJURY 244 0.0035
670 PARAESTHESIA ORAL 50 0.0035
671 FAECES DISCOLOURED 75 0.0035
672 MUSCLE TIGHTNESS 56 0.0035
673 VERTIGO 210 0.0034
674 DEEP VEIN THROMBOSIS 223 0.0034
675 TRANSAMINASES INCREASED 76 0.0034
676 HYPOAESTHESIA 511 0.0034
677 APHASIA 103 0.0034
678 BIPOLAR DISORDER 37 0.0034
679 HYPERCALCAEMIA 42 0.0034
680 HAEMATOMA 88 0.0034
681 SINUSITIS 348 0.0034
682 MUSCLE ATROPHY 43 0.0034
683 DIVERTICULITIS 94 0.0034
684 SHOCK 78 0.0034
685 VENTRICULAR TACHYCARDIA 56 0.0034
686 SKIN HAEMORRHAGE 50 0.0034
687 PRODUCT PHYSICAL ISSUE 68 0.0034
688 INSOMNIA 895 0.0034
689 MUSCULOSKELETAL STIFFNESS 294 0.0034
690 DYSPHONIA 196 0.0033
691 SKIN DISCOLOURATION 154 0.0033
692 EJECTION FRACTION DECREASED 52 0.0033
693 FEELING HOT 205 0.0033
694 PNEUMOTHORAX 53 0.0033
695 COMA 159 0.0033
696 IMMUNE SYSTEM DISORDER 44 0.0033
697 DYSGEUSIA 248 0.0033
698 CONVULSION 190 0.0033
699 LYMPHOMA 51 0.0033
700 NECK PAIN 184 0.0033
701 METASTASES TO LUNG 38 0.0033
702 LABORATORY TEST ABNORMAL 97 0.0033
703 DRY EYE 164 0.0033
704 FEAR 88 0.0033
705 RESPIRATORY TRACT INFECTION 85 0.0033
706 TOOTHACHE 59 0.0033
707 CARDIAC ARREST 269 0.0033
708 OSTEOPOROSIS 134 0.0033
709 EYE SWELLING 121 0.0032
710 PHOTOPHOBIA 61 0.0032
711 INTENTIONAL PRODUCT USE ISSUE 284 0.0032
712 EAR PAIN 63 0.0032
713 MULTI-ORGAN FAILURE 56 0.0032
714 DEPRESSED MOOD 171 0.0032
715 BLOOD PRESSURE SYSTOLIC INCREASED 63 0.0032
716 DISTURBANCE IN ATTENTION 174 0.0032
717 NASOPHARYNGITIS 594 0.0032
718 PRODUCT ADMINISTRATION ERROR 65 0.0032
719 BURSITIS 39 0.0032
720 SUBDURAL HAEMATOMA 46 0.0032
721 DYSPHAGIA 305 0.0032
722 MATERNAL EXPOSURE DURING PREGNANCY 285 0.0032
723 SPEECH DISORDER 167 0.0032
724 HALLUCINATION, VISUAL 67 0.0032
725 BLOOD CREATINE PHOSPHOKINASE INCREASED 91 0.0032
726 GASTRIC ULCER 60 0.0032
727 HAEMORRHAGE 330 0.0032
728 BURNING SENSATION 221 0.0031
729 CEREBRAL INFARCTION 77 0.0031
730 PRODUCT PRESCRIBING ERROR 75 0.0031
731 CARDIO-RESPIRATORY ARREST 131 0.0031
732 HEPATIC FAILURE 94 0.0031
733 POOR QUALITY SLEEP 67 0.0031
734 DELIRIUM 108 0.0031
735 HEART RATE DECREASED 109 0.0031
736 NIGHT SWEATS 100 0.0031
737 ANAPHYLACTIC REACTION 171 0.0031
738 URINARY RETENTION 103 0.0031
739 EAR INFECTION 82 0.0031
740 PRURITUS 1183 0.0031
741 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 219 0.0031
742 AGITATION 226 0.0031
743 INJECTION SITE PRURITUS 206 0.0031
744 LIP SWELLING 102 0.0031
745 PRODUCT USE ISSUE 575 0.0031
746 HEADACHE 1916 0.0031
747 TOOTH EXTRACTION 38 0.0031
748 JOINT STIFFNESS 80 0.0030
749 WHITE BLOOD CELL COUNT INCREASED 117 0.0030
750 MUSCULOSKELETAL DISORDER 58 0.0030
751 NEOPLASM 35 0.0030
752 DRUG EFFECT DECREASED 164 0.0030
753 PRODUCT DOSE OMISSION IN ERROR 86 0.0030
754 DEVICE USE ISSUE 53 0.0030
755 PAIN 1859 0.0030
756 HALLUCINATION 228 0.0030
757 DRUG LEVEL INCREASED 50 0.0030
758 CEREBRAL HAEMORRHAGE 108 0.0030
759 DEVICE BREAKAGE 122 0.0030
760 ARTHROPATHY 167 0.0030
761 PRODUCT DOSE OMISSION ISSUE 883 0.0030
762 TENDON RUPTURE 37 0.0030
763 PREMATURE BABY 90 0.0030
764 MIGRAINE 285 0.0030
765 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 139 0.0030
766 DRUG INTERACTION 472 0.0030
767 GASTROINTESTINAL DISORDER 266 0.0030
768 URTICARIA 497 0.0030
769 LUNG INFECTION 46 0.0030
770 SECRETION DISCHARGE 37 0.0030
771 SEIZURE 339 0.0029
772 AGEUSIA 73 0.0029
773 PHARYNGEAL OEDEMA 45 0.0029
774 SEROTONIN SYNDROME 56 0.0029
775 ISCHAEMIC STROKE 52 0.0029
776 SKIN DISORDER 97 0.0029
777 MELAENA 64 0.0029
778 ORAL PAIN 65 0.0029
779 PHARYNGITIS 36 0.0029
780 BLOOD COUNT ABNORMAL 44 0.0029
781 BEDRIDDEN 38 0.0029
782 PYREXIA 999 0.0029
783 PLATELET COUNT DECREASED 307 0.0029
784 SKIN CANCER 62 0.0029
785 ORAL DISCOMFORT 40 0.0029
786 RESPIRATORY DISORDER 86 0.0029
787 BRAIN FOG 45 0.0029
788 ALTERED STATE OF CONSCIOUSNESS 62 0.0029
789 INCORRECT PRODUCT ADMINISTRATION DURATION 62 0.0029
790 PAIN IN JAW 81 0.0029
791 SWELLING FACE 186 0.0029
792 HERPES ZOSTER 164 0.0029
793 MOBILITY DECREASED 205 0.0029
794 INJECTION SITE URTICARIA 70 0.0029
795 THERAPEUTIC RESPONSE UNEXPECTED 128 0.0029
796 DEVICE DELIVERY SYSTEM ISSUE 78 0.0028
797 IRRITABLE BOWEL SYNDROME 61 0.0028
798 METASTASES TO LIVER 50 0.0028
799 OROPHARYNGEAL PAIN 263 0.0028
800 CHILLS 333 0.0028
801 PULMONARY ARTERIAL HYPERTENSION 41 0.0028
802 JAUNDICE 76 0.0028
803 WRONG TECHNIQUE IN DRUG USAGE PROCESS 102 0.0028
804 SARS-COV-2 TEST POSITIVE 37 0.0028
805 HYPOCALCAEMIA 53 0.0028
806 TOOTH DISORDER 62 0.0028
807 THROAT TIGHTNESS 75 0.0028
808 ACUTE RESPIRATORY DISTRESS SYNDROME 49 0.0028
809 COLITIS 105 0.0028
810 DISCOMFORT 167 0.0027
811 PRODUCT TASTE ABNORMAL 37 0.0027
812 PARALYSIS 39 0.0027
813 COORDINATION ABNORMAL 38 0.0027
814 CANDIDA INFECTION 46 0.0027
815 LIVER FUNCTION TEST ABNORMAL 79 0.0027
816 JOINT SWELLING 327 0.0027
817 CHROMATURIA 61 0.0027
818 BODY TEMPERATURE INCREASED 55 0.0027
819 MENTAL DISORDER 117 0.0027
820 MOVEMENT DISORDER 86 0.0027
821 HIP ARTHROPLASTY 41 0.0027
822 MYALGIA 455 0.0027
823 CHOKING 52 0.0027
824 THERAPY CESSATION 136 0.0026
825 DRUG INEFFECTIVE 3491 0.0026
826 ARTHRALGIA 1099 0.0026
827 HYPERTHYROIDISM 38 0.0026
828 BLOOD PRESSURE FLUCTUATION 63 0.0026
829 EXPOSURE DURING PREGNANCY 163 0.0026
830 HYPERSENSITIVITY 485 0.0026
831 HAEMORRHAGE INTRACRANIAL 39 0.0026
832 ARRHYTHMIA 123 0.0026
833 EMOTIONAL DISORDER 80 0.0026
834 PARAESTHESIA 408 0.0026
835 PLASMA CELL MYELOMA 101 0.0026
836 DYSKINESIA 105 0.0026
837 ABORTION SPONTANEOUS 103 0.0026
838 HOT FLUSH 192 0.0025
839 OFF LABEL USE 2201 0.0025
840 FOETAL EXPOSURE DURING PREGNANCY 204 0.0025
841 RASH 1092 0.0025
842 PARANOIA 43 0.0025
843 BONE PAIN 146 0.0025
844 ANGIOEDEMA 110 0.0025
845 HEAD DISCOMFORT 44 0.0025
846 CRYING 90 0.0025
847 ACTIVITIES OF DAILY LIVING IMPAIRED 49 0.0025
848 NEEDLE ISSUE 72 0.0025
849 MUSCLE TWITCHING 57 0.0025
850 GLOSSODYNIA 55 0.0025
851 MOOD ALTERED 67 0.0025
852 SKIN FISSURES 48 0.0025
853 THROAT IRRITATION 110 0.0024
854 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57 0.0024
855 TOXIC EPIDERMAL NECROLYSIS 37 0.0024
856 RESTLESSNESS 89 0.0024
857 HAEMATOCHEZIA 134 0.0024
858 DEPRESSED LEVEL OF CONSCIOUSNESS 96 0.0024
859 COGNITIVE DISORDER 113 0.0024
860 GASTRIC DISORDER 83 0.0024
861 PANCYTOPENIA 135 0.0024
862 INJECTION SITE RASH 74 0.0024
863 CIRCULATORY COLLAPSE 41 0.0024
864 BLOOD BILIRUBIN INCREASED 65 0.0024
865 INFLUENZA LIKE ILLNESS 197 0.0024
866 TACHYCARDIA 211 0.0024
867 SKIN EXFOLIATION 200 0.0024
868 THROMBOCYTOPENIA 265 0.0024
869 PERITONITIS 49 0.0024
870 PANIC ATTACK 86 0.0024
871 IMMUNODEFICIENCY 35 0.0023
872 IRRITABILITY 141 0.0023
873 CHOLESTASIS 45 0.0023
874 CYTOKINE RELEASE SYNDROME 47 0.0023
875 RASH PAPULAR 52 0.0023
876 SNEEZING 52 0.0023
877 HEPATIC ENZYME INCREASED 158 0.0023
878 WHITE BLOOD CELL COUNT DECREASED 249 0.0023
879 INJECTION SITE SWELLING 176 0.0023
880 FREQUENT BOWEL MOVEMENTS 62 0.0023
881 METASTASES TO BONE 37 0.0023
882 PRODUCT AVAILABILITY ISSUE 51 0.0022
883 FLUSHING 226 0.0022
884 PRESCRIBED OVERDOSE 43 0.0022
885 TOOTH LOSS 46 0.0022
886 RESPIRATORY ARREST 61 0.0022
887 LYMPHOCYTE COUNT DECREASED 39 0.0022
888 HEPATIC CANCER 53 0.0022
889 INJECTION SITE ERYTHEMA 273 0.0022
890 NERVOUS SYSTEM DISORDER 68 0.0022
891 LYMPHADENOPATHY 77 0.0022
892 LUNG NEOPLASM MALIGNANT 89 0.0022
893 RASH ERYTHEMATOUS 103 0.0022
894 DEATH 1851 0.0021
895 PSORIATIC ARTHROPATHY 87 0.0021
896 THERAPY INTERRUPTED 152 0.0021
897 SUICIDE ATTEMPT 128 0.0021
898 ABDOMINAL PAIN LOWER 53 0.0021
899 PROCEDURAL PAIN 58 0.0021
900 MOOD SWINGS 66 0.0021
901 IMPAIRED WORK ABILITY 44 0.0021
902 EYE IRRITATION 118 0.0020
903 THERAPEUTIC RESPONSE DECREASED 122 0.0020
904 HEPATIC FUNCTION ABNORMAL 75 0.0020
905 NEUROTOXICITY 35 0.0020
906 MOUTH ULCERATION 42 0.0020
907 PSORIASIS 260 0.0020
908 ALOPECIA 390 0.0020
909 MIDDLE INSOMNIA 37 0.0020
910 ANGER 67 0.0020
911 RASH MACULAR 68 0.0019
912 OCULAR HYPERAEMIA 92 0.0019
913 PRODUCT USE IN UNAPPROVED INDICATION 479 0.0019
914 DISEASE PROGRESSION 226 0.0019
915 EYE PRURITUS 64 0.0019
916 EMOTIONAL DISTRESS 230 0.0019
917 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 64 0.0019
918 DRUG-INDUCED LIVER INJURY 59 0.0019
919 INTENTIONAL OVERDOSE 120 0.0019
920 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
921 FRACTURE 35 0.0018
922 INCORRECT DRUG ADMINISTRATION DURATION 52 0.0018
923 ADVERSE DRUG REACTION 166 0.0018
924 ABNORMAL BEHAVIOUR 72 0.0018
925 ERECTILE DYSFUNCTION 46 0.0018
926 DISEASE RECURRENCE 85 0.0018
927 PNEUMONITIS 48 0.0018
928 SUICIDAL IDEATION 161 0.0018
929 CONTRAINDICATED PRODUCT ADMINISTERED 53 0.0017
930 ERYTHEMA 355 0.0017
931 HEPATITIS 44 0.0017
932 DRY SKIN 229 0.0017
933 FEBRILE NEUTROPENIA 112 0.0017
934 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 92 0.0017
935 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
936 VAGINAL HAEMORRHAGE 72 0.0017
937 PRODUCT SUBSTITUTION ISSUE 95 0.0016
938 INTERSTITIAL LUNG DISEASE 78 0.0016
939 INFLAMMATION 83 0.0016
940 THERAPY NON-RESPONDER 71 0.0016
941 OSTEONECROSIS OF JAW 39 0.0016
942 NEUTROPHIL COUNT DECREASED 64 0.0016
943 RHEUMATOID ARTHRITIS 177 0.0016
944 INJECTION SITE REACTION 107 0.0016
945 THERAPEUTIC PRODUCT EFFECT DECREASED 68 0.0015
946 DRUG EFFECT INCOMPLETE 55 0.0015
947 BONE DENSITY DECREASED 47 0.0015
948 DRUG EXPOSURE DURING PREGNANCY 51 0.0015
949 ADVERSE EVENT 137 0.0015
950 ABNORMAL DREAMS 41 0.0015
951 NEUTROPENIA 198 0.0015
952 TARDIVE DYSKINESIA 41 0.0015
953 EXPOSURE VIA SKIN CONTACT 37 0.0014
954 LIVER INJURY 35 0.0014
955 PSYCHOTIC DISORDER 41 0.0014
956 AGGRESSION 69 0.0014
957 SEDATION 36 0.0014
958 MALIGNANT NEOPLASM PROGRESSION 140 0.0014
959 BREAST CANCER 127 0.0014
960 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
961 LEUKOPENIA 67 0.0013
962 NIGHTMARE 46 0.0013
963 C-REACTIVE PROTEIN INCREASED 47 0.0013
964 THERAPEUTIC RESPONSE SHORTENED 42 0.0013
965 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
966 EPILEPSY 37 0.0012
967 RENAL CANCER 57 0.0012
968 MULTIPLE SCLEROSIS 57 0.0012
969 OVERDOSE 252 0.0012
970 TOXICITY TO VARIOUS AGENTS 186 0.0011
971 OSTEONECROSIS 36 0.0011
972 NEOPLASM PROGRESSION 38 0.0011
973 INFUSION RELATED REACTION 72 0.0011
974 SKIN IRRITATION 49 0.0011
975 DRUG DOSE OMISSION BY DEVICE 81 0.0010
976 ECZEMA 53 0.0010
977 INCORRECT ROUTE OF DRUG ADMINISTRATION 36 0.0010
978 COLITIS ULCERATIVE 45 0.0010
979 SKIN BURNING SENSATION 72 0.0010
980 WITHDRAWAL SYNDROME 42 0.0010
981 DEVICE DISLOCATION 43 0.0010
982 ACCIDENTAL EXPOSURE TO PRODUCT 100 0.0010
983 PROSTATE CANCER 72 0.0009
984 DEVICE DIFFICULT TO USE 56 0.0008
985 ACNE 64 0.0008
986 COMPLETED SUICIDE 69 0.0008
987 NO ADVERSE EVENT 140 0.0008
988 DRUG ABUSE 62 0.0007
989 DERMATITIS ATOPIC 36 0.0007
990 DRUG WITHDRAWAL SYNDROME 50 0.0006
991 TREATMENT FAILURE 46 0.0006
992 DRUG DEPENDENCE 43 0.0003